Following the money and the mission in corporate social responsibility campaigns

Following the money and the mission in corporate social responsibility campaigns

When pharmaceutical giant Eli Lilly announced that it would cap the out-of-pocket cost of insulin at $35 or less a month, it made headlines — and sparked debate. Was the move a genuine attempt to address the affordability crisis plaguing millions of Americans with diabetes, or a savvy response to mounting public and political pressure? Around the same time, Amazon launched a telehealth clinic for its employees and their families, and Target expa…